CELULARITY
Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
CELULARITY
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2017-09-01
Address:
Florham Park, New Jersey, United States
Country:
United States
Website Url:
http://www.celularity.com
Total Employee:
101+
Status:
Active
Contact:
908-768-2170
Email Addresses:
[email protected]
Total Funding:
400 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-08-31 | Caricord | Caricord acquired by Celularity | N/A |
Investors List
Sorrento Therapeutics
Sorrento Therapeutics investment in Post-IPO Equity - Celularity
Dragasac Limited
Dragasac Limited investment in Post-IPO Equity - Celularity
Starr Insurance Companies
Starr Insurance Companies investment in Post-IPO Equity - Celularity
Section 32
Section 32 investment in Venture Round - Celularity
Celgene
Celgene investment in Venture Round - Celularity
Heritage Group
Heritage Group investment in Venture Round - Celularity
Tony Robbins
Tony Robbins investment in Venture Round - Celularity
Bill Maris
Bill Maris investment in Venture Round - Celularity
United Therapeutics
United Therapeutics investment in Venture Round - Celularity
Human Longevity
Human Longevity investment in Venture Round - Celularity
Official Site Inspections
http://www.celularity.com Semrush global rank: 2.26 M Semrush visits lastest month: 8.43 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Celularity"
About - Celularity
Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including …See details»
Celularity - Crunchbase Company Profile & Funding
Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells …See details»
Investor Relations - Celularity
May 21, 2024 Celularity Inc. (Nasdaq: CELU) headquartered in Florham Park, N.J., is a biotechnology company leading the next evolution in cellular and regenerative medicine by developing allogeneic cryopreserved off-the-shelf …See details»
Celularity Inc. - LinkedIn
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived ...See details»
Celularity Inc. (CELU) Company Profile & Overview - Stock Analysis
Nov 22, 2024 Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious …See details»
Celularity Provides Corporate Update - Yahoo Finance
FLORHAM PARK, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, has issued a ...See details»
Celularity Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Celularity has 5 employees across 3 locations and $22.77 m in annual revenue in FY 2023. See insights on Celularity including office locations, competitors, revenue, financials, …See details»
Celularity Founder, Chairman and Chief Executive Officer, Robert J ...
Jul 7, 2021 “Celularity seeks to be a disruptive, game-changer in the rapidly evolving cellular medicine industry by developing transformative therapies for patients with neurological …See details»
Leadership - Celularity
Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent …See details»
Celularity: Productizing Placental-Derived Stem Cells …
Apr 28, 2021 Celularity CEO Robert Hariri, MD, PhD. There have been some big biotech special purpose acquisition company (SPAC) deals over the past six months or so, including 23andMe, Sema4 and Tango ...See details»
Celularity Inc. (CELU) Stock Price, News, Quote & History - Yahoo …
Find the latest Celularity Inc. (CELU) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Celularity and GX Acquisition Corp. Announce Merger Agreement …
Jan 8, 2021 GX Acquisition Corp.'s stockholders and other interested persons are advised to read, once available, the Registration Statement, including the preliminary proxy statement / …See details»
Corporate Governance - Celularity
The Board of Directors of Celularity, Inc. sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate …See details»
Celularity Inc. Announces Receipt of Nasdaq Notification - Yahoo …
4 days ago FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing …See details»
Celularity to Present Data Showing Cancer Tumor Reduction
Jul 3, 2024 Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells Company presenting an in vivo study of PT …See details»
Press Releases - Celularity
Nov 7, 2024 Celularity, Inc. (Nasdaq: CELU) headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off …See details»
How Celularity is Leading the Next Evolution in Cellular Medicine
Nov 18, 2020 Celularity is a clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies derived from the postpartum human placenta. Using proprietary …See details»
Celularity Completes Strategic Review of 2023 Initiatives, Including ...
Jan 26, 2023 Celularity’s advanced biomaterial products include: Story Continues Biovance ® , a decellularized, dehydrated human amniotic membrane derived from the placenta of a healthy, …See details»
Celularity Reports Third Quarter 2021 Financial Results and …
FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived allogeneic …See details»